Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.

Dang Q, Kasibhatla SR, Xiao W, Liu Y, Dare J, Taplin F, Reddy KR, Scarlato GR, Gibson T, van Poelje PD, Potter SC, Erion MD.

J Med Chem. 2010 Jan 14;53(1):441-51. doi: 10.1021/jm901420x.

PMID:
20055427
2.

Malingering and retrograde amnesia: the historic case of the Collegno amnesic.

Zago S, Sartori G, Scarlato G.

Cortex. 2004 Jun;40(3):519-32.

PMID:
15259331
3.

Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate.

Jung S, Siglienti I, Grauer O, Magnus T, Scarlato G, Toyka K.

J Neuroimmunol. 2004 Mar;148(1-2):63-73.

PMID:
14975587
4.

High mutational burden in the mtDNA control region from aged muscles: a single-fiber study.

Del Bo R, Crimi M, Sciacco M, Malferrari G, Bordoni A, Napoli L, Prelle A, Biunno I, Moggio M, Bresolin N, Scarlato G, Pietro Comi G.

Neurobiol Aging. 2003 Oct;24(6):829-38.

PMID:
12927765
5.

The 129 codon polymorphism of the prion protein gene influences earlier cognitive performance in Down syndrome subjects.

Del Bo R, Comi GP, Giorda R, Crimi M, Locatelli F, Martinelli-Boneschi F, Pozzoli U, Castelli E, Bresolin N, Scarlato G.

J Neurol. 2003 Jun;250(6):688-92.

PMID:
12796830
6.

A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome.

Crimi M, Galbiati S, Moroni I, Bordoni A, Perini MP, Lamantea E, Sciacco M, Zeviani M, Biunno I, Moggio M, Scarlato G, Comi GP.

Neurology. 2003 Jun 10;60(11):1857-61.

PMID:
12796552
7.

Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency.

Prelle A, Sciacco M, Tancredi L, Fagiolari G, Comi GP, Ciscato P, Serafini M, Fortunato F, Zecca C, Gallanti A, Chiveri L, Bresolin N, Scarlato G, Moggio M.

Acta Neuropathol. 2003 Jun;105(6):537-42. Epub 2003 Mar 4.

PMID:
12734659
8.

Severe chronic sensory-motor polyneuropathy: coexistence of 3 unrelated etiologies in a type 1 diabetic patient. A case report and review of the literature.

Micco A, Nobile-Orazio E, Baron P, Conti G, Napoli L, Serafini M, Scarlato G, Scarpini E.

J Peripher Nerv Syst. 2003 Mar;8(1):23-8. Review.

PMID:
12678551
9.

Movement-related modulation of neural activity in human basal ganglia and its L-DOPA dependency: recordings from deep brain stimulation electrodes in patients with Parkinson's disease.

Priori A, Foffani G, Pesenti A, Bianchi A, Chiesa V, Baselli G, Caputo E, Tamma F, Rampini P, Egidi M, Locatelli M, Barbieri S, Scarlato G.

Neurol Sci. 2002 Sep;23 Suppl 2:S101-2.

PMID:
12548363
10.

Neuroectodermal and microglial differentiation of bone marrow cells in the mouse spinal cord and sensory ganglia.

Corti S, Locatelli F, Donadoni C, Strazzer S, Salani S, Del Bo R, Caccialanza M, Bresolin N, Scarlato G, Comi GP.

J Neurosci Res. 2002 Dec 15;70(6):721-33.

PMID:
12444594
11.

Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL.

Lucchiari S, Donati MA, Parini R, Melis D, Gatti R, Bresolin N, Scarlato G, Comi GP.

Hum Mutat. 2002 Dec;20(6):480.

PMID:
12442284
12.

Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment.

Corti S, Locatelli F, Strazzer S, Salani S, Del Bo R, Soligo D, Bossolasco P, Bresolin N, Scarlato G, Comi GP.

Exp Neurol. 2002 Oct;177(2):443-52.

PMID:
12429190
13.

Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease.

Priori A, Cinnante C, Pesenti A, Carpo M, Cappellari A, Nobile-Orazio E, Scarlato G, Barbieri S.

Brain. 2002 Nov;125(Pt 11):2481-90.

PMID:
12390974
14.

Metabolic and drug-induced muscle disorders.

Scarlato G, Comi GP.

Curr Opin Neurol. 2002 Oct;15(5):533-8. Review.

PMID:
12351996
15.

Evidence and age-related distribution of mtDNA D-loop point mutations in skeletal muscle from healthy subjects and mitochondrial patients.

Del Bo R, Bordoni A, Martinelli Boneschi F, Crimi M, Sciacco M, Bresolin N, Scarlato G, Comi GP.

J Neurol Sci. 2002 Oct 15;202(1-2):85-91.

PMID:
12220698
16.

Lack of apoptosis in patients with progressive external ophthalmoplegia and mutated adenine nucleotide translocator-1 gene.

Fagiolari G, Sciacco M, Chiveri L, Lamperti C, Comi GP, Scarlato G, Moggio M, Prelle A.

Muscle Nerve. 2002 Aug;26(2):265-9.

PMID:
12210391
17.

Multifocal motor neuropathy and Campylobacter jejuni reactivity.

Terenghi F, Allaria S, Scarlato G, Nobile-Orazio E.

Neurology. 2002 Jul 23;59(2):282-4.

PMID:
12136073
18.

Alternative sources of neurons and glia from somatic stem cells.

Torrente Y, Belicchi M, Pisati F, Pagano SF, Fortunato F, Sironi M, D'Angelo MG, Parati EA, Scarlato G, Bresolin N.

Cell Transplant. 2002;11(1):25-34.

PMID:
12095217
19.

A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse.

Corti S, Strazzer S, Del Bo R, Salani S, Bossolasco P, Fortunato F, Locatelli F, Soligo D, Moggio M, Ciscato P, Prelle A, Borsotti C, Bresolin N, Scarlato G, Comi GP.

Exp Cell Res. 2002 Jul 1;277(1):74-85.

PMID:
12061818
20.

Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study.

Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, Bonaiuto S, Perissinotto E, Scarlato G, Farchi G, Inzitari D; ILSA Working Group.

J Am Geriatr Soc. 2002 Jan;50(1):41-8.

PMID:
12028245
21.

Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.

Nobile-Orazio E, Cappellari A, Meucci N, Carpo M, Terenghi F, Bersano A, Priori A, Barbieri S, Scarlato G.

J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):761-6.

22.

Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels.

Prelle A, Tancredi L, Sciacco M, Chiveri L, Comi GP, Battistel A, Bazzi P, Martinelli Boneschi F, Bagnardi V, Ciscato P, Bordoni A, Fortunato F, Strazzer S, Bresolin N, Scarlato G, Moggio M.

J Neurol. 2002 Mar;249(3):305-11.

PMID:
11993531
23.

Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area.

Lucchiari S, Fogh I, Prelle A, Parini R, Bresolin N, Melis D, Fiori L, Scarlato G, Comi GP.

Am J Med Genet. 2002 May 1;109(3):183-90.

PMID:
11977176
24.

Interleukin-1 beta and interferon-gamma induce proliferation and apoptosis in cultured Schwann cells.

Conti G, De Pol A, Scarpini E, Vaccina F, De Riz M, Baron P, Tiriticco M, Scarlato G.

J Neuroimmunol. 2002 Mar;124(1-2):29-35.

PMID:
11958819
25.

IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease.

Scarpini E, Galimberti D, Baron P, Clerici R, Ronzoni M, Conti G, Scarlato G.

J Neurol Sci. 2002 Mar 15;195(1):41-6.

PMID:
11867072
26.

Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-1beta and p75NTR.

Conti G, Scarpini E, Baron P, Livraghi S, Tiriticco M, Bianchi R, Vedeler C, Scarlato G.

J Neurol Sci. 2002 Mar 15;195(1):35-40.

PMID:
11867071
27.

Women with pregnancy-related polymyositis and high serum CK levels in the newborn.

Messina S, Fagiolari G, Lamperti C, Cavaletti G, Prelle A, Scarlato G, Bresolin M, Moggio M, Sciacco M.

Neurology. 2002 Feb 12;58(3):482-4.

PMID:
11839858
28.

A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family.

Napoli L, Bordoni A, Zeviani M, Hadjigeorgiou GM, Sciacco M, Tiranti V, Terentiou A, Moggio M, Papadimitriou A, Scarlato G, Comi GP.

Neurology. 2001 Dec 26;57(12):2295-8.

PMID:
11756613
29.

Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins.

Meda L, Baron P, Scarlato G.

Neurobiol Aging. 2001 Nov-Dec;22(6):885-93. Review.

PMID:
11754995
30.

Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells.

Menichella DM, Arroyo EJ, Awatramani R, Xu T, Baron P, Vallat JM, Balsamo J, Lilien J, Scarlato G, Kamholz J, Scherer SS, Shy ME.

Mol Cell Neurosci. 2001 Dec;18(6):606-18.

PMID:
11749037
31.

Transient improvement induced by motor fatigue in focal occupational dystonia: the handgrip test.

Pesenti A, Priori A, Scarlato G, Barbieri S.

Mov Disord. 2001 Nov;16(6):1143-7.

PMID:
11748750
32.

The pathogenesis of ALS: implications for treatment strategies.

Silani V, Braga M, Cardin V, Scarlato G.

Neurol Neurochir Pol. 2001;35(1 Suppl):25-39. Review.

PMID:
11732278
33.

Biodistribution studies of 99mTc-labeled myoblasts in a murine model of muscular dystrophy.

Colombo FR, Torrente Y, Casati R, Benti R, Corti S, Salani S, D'Angelo MG, DeLiso A, Scarlato G, Bresolin N, Gerundini P.

Nucl Med Biol. 2001 Nov;28(8):935-40.

PMID:
11711313
34.

Production of IL-6 by human myoblasts stimulated with Abeta: relevance in the pathogenesis of IBM.

Baron P, Galimberti D, Meda L, Scarpini E, Conti G, Cogiamanian F, Scarlato G.

Neurology. 2001 Nov 13;57(9):1561-5.

PMID:
11706091
35.

Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation.

Sciacco M, Prelle A, Comi GP, Napoli L, Battistel A, Bresolin N, Tancredi L, Lamperti C, Bordoni A, Fagiolari G, Ciscato P, Chiveri L, Perini MP, Fortunato F, Adobbati L, Messina S, Toscano A, Martinelli-Boneschi F, Papadimitriou A, Scarlato G, Moggio M.

J Neurol. 2001 Sep;248(9):778-88.

PMID:
11596783
36.

Decreased EMG inhibition following electrical stimulation over muscle tendons in myopathies.

Priori A, Cinnante C, Pesenti A, Gallanti A, Cappellari A, Scarlato G, Barbieri S.

Clin Neurophysiol. 2001 Oct;112(10):1931-5.

PMID:
11595154
37.

Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis.

Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, Torrente Y, Scarlato G, Bresolin N.

Ann Neurol. 2001 Aug;50(2):202-7.

PMID:
11506403
38.

Limb immobilization for the treatment of focal occupational dystonia.

Priori A, Pesenti A, Cappellari A, Scarlato G, Barbieri S.

Neurology. 2001 Aug 14;57(3):405-9.

PMID:
11502904
39.

Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: preliminary physiological results.

Priori A, Cinnante C, Genitrini S, Pesenti A, Tortora G, Bencini C, Barelli MV, Buonamici V, Carella F, Girotti F, Soliveri P, Magrini F, Morganti A, Albanese A, Broggi S, Scarlato G, Barbieri S.

Neurol Sci. 2001 Feb;22(1):85-6.

PMID:
11487214
40.

Human developing motor neurons as a tool to study ALS.

Silani V, Braga M, Botturi A, Cardin V, Bez A, Pizzuti A, Scarlato G.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Mar;2 Suppl 1:S69-76. Review.

PMID:
11465927
41.

Chemotactic factors enhance myogenic cell migration across an endothelial monolayer.

Corti S, Salani S, Del Bo R, Sironi M, Strazzer S, D'Angelo MG, Comi GP, Bresolin N, Scarlato G.

Exp Cell Res. 2001 Aug 1;268(1):36-44.

PMID:
11461116
42.

Visual loss and enlarged extraocular muscles from metastatic signet ring carcinoma.

Clerici R, Conti G, Scarpini E, De Riz M, Baron PL, Scarlato G.

J Neurol. 2001 Apr;248(4):336-8. No abstract available.

PMID:
11374103
43.

Primary beta-sarcoglycanopathy manifesting as recurrent exercise-induced myoglobinuria.

Cagliani R, Comi GP, Tancredi L, Sironi M, Fortunato F, Giorda R, Bardoni A, Moggio M, Prelle A, Bresolin N, Scarlato G.

Neuromuscul Disord. 2001 May;11(4):389-94.

PMID:
11369190
44.

In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells: evidence of programmed cell death after muscle cell transplantation.

Del Bo R, Torrente Y, Corti S, D'Angelo MG, Comi GP, Fagiolari G, Salani S, Cova A, Pisati F, Moggio M, Ausenda C, Scarlato G, Bresolin N.

Cell Transplant. 2001 Mar-Apr;10(2):209-21.

PMID:
11332636
45.

Lack of apoptosis in mitochondrial encephalomyopathies.

Sciacco M, Fagiolari G, Lamperti C, Messina S, Bazzi P, Napoli L, Chiveri L, Prelle A, Comi GP, Bresolin N, Scarlato G, Moggio M.

Neurology. 2001 Apr 24;56(8):1070-4.

PMID:
11320180
46.

Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice.

Torrente Y, Tremblay JP, Pisati F, Belicchi M, Rossi B, Sironi M, Fortunato F, El Fahime M, D'Angelo MG, Caron NJ, Constantin G, Paulin D, Scarlato G, Bresolin N.

J Cell Biol. 2001 Jan 22;152(2):335-48.

47.

Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies.

Cavanna B, Jiang H, Allaria S, Carpo M, Scarlato G, Nobile-Orazio E.

J Neuroimmunol. 2001 Mar 1;114(1-2):226-31.

PMID:
11240036
48.

T-antigen regulated expression reduces apoptosis of tag-transformed human myoblasts.

Corti S, Salani S, Del Bo R, Torrente Y, Strazzer S, Belicchi M, Paganoni S, Li Z, Comi GP, Bresolin N, Paulin D, Scarlato G.

Cell Mol Life Sci. 2001 Jan;58(1):135-40.

PMID:
11229812
49.

Down's syndrome fibroblasts anticipate the accumulation of specific ageing-related mtDNA mutations.

Del Bo R, Comi GP, Perini MP, Strazzer S, Bresolin N, Scarlato G.

Ann Neurol. 2001 Jan;49(1):137-8. No abstract available.

PMID:
11198288
50.

Supplemental Content

Loading ...
Support Center